17beta-estradiol multiple interactions ISO RGD:2299183 6480464 [Progesterone co-treated with Estradiol] results in increased expression of MIR155 mRNA CTD PMID:22950660 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MIR155 mRNA] CTD PMID:24066068 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of MIR155 mRNA CTD PMID:24066068 2-acetamidofluorene increases expression ISO RGD:7489038 6480464 2-Acetylaminofluorene results in increased expression of MIR155 mRNA CTD PMID:19167416 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of MIR155 mRNA CTD PMID:29860048 all-trans-retinoic acid multiple interactions ISO RGD:2299183 6480464 [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3, 3-bis(2-aminoethyl)-1-triazene] results in decreased expression of MIR155 mRNA CTD PMID:23284745 arsenite(3-) multiple interactions ISO RGD:2299183 6480464 MIR155 promotes the reaction [arsenite results in decreased expression of NFE2L2 mRNA], MIR155 promotes the reaction [arsenite results in decreased expression of NFE2L2 protein] CTD PMID:28688901 arsenite(3-) increases expression ISO RGD:2299183 6480464 arsenite results in increased expression of MIR155 mRNA CTD PMID:28688901 arsenous acid increases expression ISO RGD:2299183 6480464 Arsenic Trioxide results in increased expression of MIR155 mRNA CTD PMID:22072212 arsenous acid multiple interactions ISO RGD:2299183 6480464 MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein] more ... CTD PMID:29260515 arsenous acid decreases expression ISO RGD:2299183 6480464 Arsenic Trioxide results in decreased expression of MIR155 mRNA CTD PMID:29260515 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:2299183 6480464 7 more ... CTD PMID:20382639 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of MIR155 mRNA CTD PMID:26456178 bisphenol A increases expression ISO RGD:2299183 6480464 bisphenol A results in increased expression of MIR155 mRNA CTD PMID:20417706 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of MIR155 mRNA CTD PMID:29038090 cadmium dichloride decreases expression ISO RGD:2299183 6480464 Cadmium Chloride results in decreased expression of MIR155 mRNA CTD PMID:27375191 , PMID:27510461 cadmium dichloride multiple interactions ISO RGD:2299183 6480464 KRAS protein inhibits the reaction [Cadmium Chloride results in decreased expression of MIR155 mRNA] CTD PMID:27510461 carbamazepine increases expression ISO RGD:2299183 6480464 Carbamazepine results in increased expression of MIR155 mRNA CTD PMID:29644860 carbon atom increases expression ISO RGD:2299183 6480464 Carbon results in increased expression of MIR155 mRNA CTD PMID:26068961 carboplatin multiple interactions ISO RGD:2299183 6480464 [Carboplatin co-treated with Chloroquine] results in increased expression of MIR155 mRNA CTD PMID:27692344 chloroquine multiple interactions ISO RGD:2299183 6480464 [Carboplatin co-treated with Chloroquine] results in increased expression of MIR155 mRNA CTD PMID:27692344 choline multiple interactions EXP 6480464 [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... CTD PMID:20548288 cisplatin multiple interactions EXP 6480464 MIR155 gene mutant form promotes the reaction [Cisplatin results in increased expression of FOS mRNA], MIR155 gene mutant form promotes the reaction [Cisplatin results in increased expression of FOS protein] CTD PMID:25015656 cisplatin increases response to substance EXP 6480464 MIR155 gene mutant form results in increased susceptibility to Cisplatin CTD PMID:25015656 cisplatin increases expression ISO RGD:7489038 6480464 Cisplatin results in increased expression of MIR155 mRNA CTD PMID:24880025 clofibrate decreases expression ISO RGD:7489038 6480464 Clofibrate results in decreased expression of MIR155 mRNA CTD PMID:28495587 cypermethrin multiple interactions EXP 6480464 [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein more ... CTD PMID:29471534 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of MIR155 mRNA CTD PMID:29471534 Deoxycorticosterone acetate multiple interactions ISO RGD:7489038 6480464 [Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in increased expression of MIR155 mRNA, Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in increased expression of MIR155 mRNA] CTD PMID:30290168 diarsenic trioxide decreases expression ISO RGD:2299183 6480464 Arsenic Trioxide results in decreased expression of MIR155 mRNA CTD PMID:29260515 diarsenic trioxide increases expression ISO RGD:2299183 6480464 Arsenic Trioxide results in increased expression of MIR155 mRNA CTD PMID:22072212 diarsenic trioxide multiple interactions ISO RGD:2299183 6480464 MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein] more ... CTD PMID:29260515 doxorubicin multiple interactions ISO RGD:2299183 6480464 Doxorubicin promotes the reaction [hydroquinone results in increased expression of MIR155 mRNA] CTD PMID:30448557 elemental carbon increases expression ISO RGD:2299183 6480464 Carbon results in increased expression of MIR155 mRNA CTD PMID:26068961 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MIR155 mRNA CTD PMID:28329830 folic acid multiple interactions EXP 6480464 [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... CTD PMID:20548288 gentamycin increases expression ISO RGD:7489038 6480464 Gentamicins results in increased expression of MIR155 mRNA CTD PMID:22705808 , PMID:24863737 hydrogen peroxide increases expression ISO RGD:2299183 6480464 Hydrogen Peroxide results in increased expression of MIR155 mRNA CTD PMID:26339600 hydroquinone increases expression ISO RGD:2299183 6480464 hydroquinone results in increased expression of MIR155 mRNA CTD PMID:30448557 hydroquinone multiple interactions ISO RGD:2299183 6480464 Doxorubicin promotes the reaction [hydroquinone results in increased expression of MIR155 mRNA] more ... CTD PMID:30448557 isoprenaline increases expression ISO RGD:7489038 6480464 Isoproterenol results in increased expression of MIR155 mRNA CTD PMID:29355689 isorhamnetin multiple interactions EXP 6480464 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155 mRNA] CTD PMID:20579867 L-methionine multiple interactions EXP 6480464 [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... CTD PMID:20548288 lamotrigine increases expression ISO RGD:2299183 6480464 lamotrigine results in increased expression of MIR155 mRNA CTD PMID:29644860 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of MIR155 mRNA CTD PMID:20579867 lipopolysaccharide multiple interactions EXP 6480464 3-methylquercetin inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155 mRNA], Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155 mRNA] CTD PMID:20579867 lithium chloride increases expression ISO RGD:7489038 6480464 Lithium Chloride results in increased expression of MIR155 mRNA CTD PMID:19254429 metformin multiple interactions ISO RGD:7489038 6480464 Metformin inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride, Dietary] results in increased expression of MIR155 mRNA] CTD PMID:30290168 methamidophos decreases expression ISO RGD:2299183 6480464 methamidophos results in decreased expression of MIR155 mRNA CTD PMID:30602960 morphine increases expression ISO RGD:2299183 6480464 Morphine results in increased expression of MIR155 CTD PMID:20564181 paracetamol affects expression ISO RGD:7489038 6480464 Acetaminophen affects the expression of MIR155 mRNA CTD PMID:24863736 paracetamol increases expression ISO RGD:7489038 6480464 Acetaminophen results in increased expression of MIR155 mRNA CTD PMID:27397436 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2299183 6480464 perfluorooctane sulfonic acid results in increased expression of MIR155 mRNA CTD PMID:26844784 perfluorooctane-1-sulfonic acid increases expression ISO RGD:7489038 6480464 perfluorooctane sulfonic acid results in increased expression of MIR155 mRNA CTD PMID:26844784 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:2299183 6480464 CAT protein inhibits the reaction [perfluorooctane sulfonic acid results in increased expression of MIR155 mRNA] more ... CTD PMID:26844784 phenobarbital decreases expression ISO RGD:7489038 6480464 Phenobarbital results in decreased expression of MIR155 mRNA CTD PMID:28495587 piperacillin increases expression ISO RGD:2299183 6480464 Piperacillin results in increased expression of MIR155 mRNA CTD PMID:29644860 poly(I:C) multiple interactions EXP 6480464 MIR155 mRNA inhibits the reaction [Progesterone inhibits the reaction [Poly I-C results in increased expression of MIR155 mRNA]], Progesterone inhibits the reaction [Poly I-C results in increased expression of MIR155 mRNA] CTD PMID:22546503 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of MIR155 mRNA CTD PMID:22546503 progesterone multiple interactions EXP 6480464 MIR155 mRNA inhibits the reaction [Progesterone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of IL6 protein]] more ... CTD PMID:22546503 progesterone multiple interactions ISO RGD:2299183 6480464 [Progesterone co-treated with Estradiol] results in increased expression of MIR155 mRNA CTD PMID:22950660 progesterone increases expression ISO RGD:2299183 6480464 Progesterone results in increased expression of MIR155 mRNA CTD PMID:22950660 propofol decreases expression ISO RGD:7489038 6480464 Propofol results in decreased expression of MIR155 mRNA CTD PMID:26254736 puromycin affects expression ISO RGD:7489038 6480464 Puromycin affects the expression of MIR155 CTD PMID:30169741 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155 mRNA] CTD PMID:20579867 resveratrol decreases expression ISO RGD:2299183 6480464 resveratrol results in decreased expression of MIR155 mRNA CTD PMID:23251493 silver atom increases expression ISO RGD:2299183 6480464 Silver results in increased expression of MIR155 mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:2299183 6480464 Silver results in increased expression of MIR155 mRNA CTD PMID:26551752 Sinomenine multiple interactions EXP 6480464 sinomenine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MIR155 mRNA] CTD PMID:24066068 sodium arsenite decreases expression ISO RGD:2299183 6480464 sodium arsenite results in decreased expression of MIR155 mRNA CTD PMID:24431212 sodium arsenite increases expression ISO RGD:2299183 6480464 sodium arsenite results in increased expression of MIR155 mRNA CTD PMID:29240254 sodium arsenite multiple interactions ISO RGD:2299183 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [sodium arsenite results in increased expression of MIR155 mRNA] more ... CTD PMID:29240254 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of MIR155 mRNA CTD PMID:29127033 sodium fluoride increases expression ISO RGD:2299183 6480464 Sodium Fluoride results in increased expression of MIR155 mRNA CTD PMID:26339601 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of MIR155 mRNA CTD PMID:27629361 sulfamethoxazole increases expression ISO RGD:2299183 6480464 Sulfamethoxazole results in increased expression of MIR155 mRNA CTD PMID:29644860 tetrachloromethane increases expression ISO RGD:7489038 6480464 Carbon Tetrachloride results in increased expression of MIR155 mRNA CTD PMID:27397436 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MIR155 mRNA CTD PMID:25270620 trichostatin A multiple interactions ISO RGD:2299183 6480464 trichostatin A promotes the reaction [hydroquinone results in increased expression of MIR155 mRNA] CTD PMID:30448557 zinc atom decreases expression ISO RGD:2299183 6480464 Zinc deficiency results in decreased expression of MIR155 mRNA CTD PMID:22171008 zinc(0) decreases expression ISO RGD:2299183 6480464 Zinc deficiency results in decreased expression of MIR155 mRNA CTD PMID:22171008
Gene-Chemical Interaction Annotations
